Jin Medical International Ltd. (ZJYL) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Jin Medical International Ltd. (ZJYL) Healthcare & Pipeline Overview

Jin Medical International Ltd., founded in 2006, designs, develops, manufactures, and sells wheelchairs and living aids for people with disabilities. Operating in China and internationally, the company also offers oxygen concentrators and bathing machines, addressing the needs of a growing aging population.

What Is the Investment Thesis for ZJYL?

Jin Medical International Ltd. presents a focused investment opportunity within the medical instruments and supplies sector, specifically targeting the mobility aids market. With a market capitalization of $16.1M and a P/E ratio of 14.09, the company demonstrates potential value. A key growth catalyst is the increasing global demand for wheelchairs and living aids, driven by aging populations and a rising prevalence of mobility impairments. The company's existing profit margin of 5.8% and gross margin of 29.8% indicate a solid foundation for profitability. However, the high beta of 9.37 suggests significant volatility. Investors may want to evaluate the company's growth opportunities in expanding its product line and geographic reach, balanced against the risks of competition and regulatory changes in the healthcare sector.

Based on FMP financials and quantitative analysis

ZJYL Key Highlights

Market capitalization of $16.1M indicates a small-cap company with potential for growth.

• P/E ratio of 14.09 suggests the company may be undervalued compared to its earnings.
• Profit margin of 5.8% demonstrates the company's ability to generate profit from its revenue.
• Gross margin of 29.8% reflects the company's efficiency in managing production costs.
• Beta of 9.37 indicates high volatility compared to the market, suggesting higher risk and potential reward.

Who Are ZJYL's Competitors?

ZJYL is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ZJYL's Key Strengths?

Specialized in wheelchair and living aid products.

• Established presence in China and international markets.
• Offers a range of products including oxygen concentrators and bathing machines.
• Subsidiary of Jolly Harmony Enterprises Limited.

What Are ZJYL's Weaknesses?

Small market capitalization.

• High beta indicates significant volatility.
• Limited financial resources compared to larger competitors.
• Dependence on parent company for resources and support.

What Could Drive ZJYL Stock Higher?

Launch of new advanced wheelchair models in Q3 2026, expected to drive revenue growth.

• Increasing demand for mobility aids due to the aging global population.
• Expansion into new geographic markets in Southeast Asia by Q4 2026.

What Are the Key Risks for ZJYL?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

• Intense competition from larger medical device manufacturers could erode market share.
• Regulatory changes in the healthcare sector may increase compliance costs.
• Economic downturns could reduce consumer spending on non-essential medical devices.
• Fluctuations in currency exchange rates could impact profitability.

What Are the Growth Opportunities for ZJYL?

• Expanding Product Line: Jin Medical International can capitalize on the growing demand for specialized living aids by expanding its product line to include advanced mobility solutions and assistive technologies. The global assistive technology market is projected to reach $36.4 billion by 2028, presenting a substantial opportunity for revenue growth. By investing in research and development, the company can introduce innovative products that cater to the evolving needs of its target demographic, enhancing its competitive advantage.
• Geographic Expansion: The company can pursue geographic expansion into new markets, particularly in developing countries where the demand for affordable mobility aids is high. The Asia-Pacific region, with its large aging population and increasing healthcare spending, represents a significant growth opportunity. By establishing strategic partnerships with local distributors and healthcare providers, Jin Medical International can effectively penetrate these markets and establish a strong presence.
• Strategic Partnerships: Collaborating with rehabilitation centers, hospitals, and other healthcare providers can create new avenues for growth and market penetration. By offering customized solutions and integrating its products into comprehensive rehabilitation programs, Jin Medical International can enhance its value proposition and build stronger relationships with key stakeholders. These partnerships can also facilitate access to new customer segments and generate recurring revenue streams.
• Online Sales Channels: Developing a robust online sales channel can expand the company's reach and improve accessibility for customers, particularly in remote areas. The e-commerce market for medical devices is growing rapidly, driven by increasing internet penetration and changing consumer preferences. By investing in a user-friendly online platform and implementing effective digital marketing strategies, Jin Medical International can capture a larger share of the online market and reduce its reliance on traditional distribution channels.
• Government Initiatives: Capitalizing on government initiatives and subsidies aimed at supporting individuals with disabilities can drive sales and increase market share. Many countries offer financial assistance and incentives to promote the adoption of assistive technologies. By actively engaging with government agencies and participating in relevant programs, Jin Medical International can leverage these opportunities to expand its customer base and enhance its brand reputation.

What Are ZJYL's Competitive Advantages?

• Established manufacturing capabilities.
• Focus on affordable mobility solutions.
• Distribution network in China and internationally.

What Does ZJYL Do?

Jin Medical International Ltd., established in 2006 and headquartered in Changzhou, China, specializes in the design, development, manufacturing, and sale of wheelchairs and other living aids. These products are primarily targeted towards individuals with disabilities or impaired mobility, addressing a critical need both in China and in international markets. The company's product portfolio includes not only a variety of wheelchair models but also other essential living aids such as oxygen concentrators and bathing machines, catering to a broader spectrum of needs for its target demographic. As a subsidiary of Jolly Harmony Enterprises Limited, Jin Medical International leverages its parent company's resources and expertise to enhance its operational capabilities and market reach. The company's commitment to innovation and quality is reflected in its product design and manufacturing processes, ensuring that its offerings meet the evolving needs of its customers. Jin Medical International's strategic focus on both domestic and international markets allows it to capitalize on the increasing demand for assistive devices driven by aging populations and rising awareness of disability-related issues. With a workforce of 269 employees, the company maintains a lean and efficient operational structure, enabling it to respond effectively to market dynamics and customer demands.

What Products and Services Does ZJYL Offer?

• Designs and develops wheelchairs for people with disabilities or impaired mobility.
• Manufactures wheelchairs and other living aids.
• Sells wheelchairs and living aids in China and internationally.
• Offers oxygen concentrators for respiratory support.
• Provides bathing machines to assist with personal hygiene.
• Targets individuals with disabilities or impaired mobility.

How Does ZJYL Make Money?

• Designs and manufactures wheelchairs and living aids.
• Sells products directly to consumers and through distributors.
• Generates revenue from product sales in China and internationally.

What Industry Does ZJYL Operate In?

Jin Medical International Ltd. operates within the medical instruments and supplies industry, which is experiencing growth due to the increasing global aging population and rising prevalence of chronic diseases. The market for wheelchairs and mobility aids is expanding, driven by technological advancements and a focus on improving the quality of life for individuals with disabilities. The competitive landscape includes both large multinational corporations and smaller specialized manufacturers. Jin Medical International's focus on affordability and accessibility in both China and international markets positions it to capture a significant share of this growing market.

Who Are ZJYL's Key Customers?

• Individuals with disabilities or impaired mobility.
• Hospitals and rehabilitation centers.
• Distributors of medical equipment.

Jin Medical International Ltd.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 2.27 places it in the grey zone, a middle ground that warrants monitoring.

Quarterly Financial Performance: Jin Medical International Ltd.

Revenue for Jin Medical International Ltd. came in at $8.9M during Q2 FY2026, a 17.5% contraction versus the preceding quarter. The company recorded a net loss of $108K, with diluted EPS of $-0.01. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, ZJYL averaged $0.09 in diluted EPS.

ZJYL Valuation & Market Position

With a $16.1M market cap, Jin Medical International Ltd. sits in the micro-cap segment of the market. Relative to its peer group, ZJYL's quantitative score of 40/100 is roughly in line with the peer average of 43/100.

Return on equity for Jin Medical International Ltd. stands at 3.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 2.1%, showing how much profit it generates from its asset base. ZJYL trades at a trailing price-to-earnings ratio of 14.09, below the Healthcare sector average of ~21.50x. Its free cash flow yield is -43.2%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.95 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is 7.3%, the inverse of the P/E and a quick read on earnings relative to price.

Company Profile

Jin Medical International Ltd. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Changzhou, CN. The company is led by CEO Erqi Wang. ZJYL has traded publicly since 2023.

ZJYL Financials

ZJYL Latest News

ZJYL Analyst Consensus

ZJYL MoonshotScore

Jin Medical International Ltd. Healthcare Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources